Answers are grounded in this paper and cite their sources.
Magnetic targeting can improve localization of transplanted cells, but most implementations utilize endpoint assessments rather than real‐time longitudinal monitoring to assist and verify in vivo cell delivery and distribution. Here we develop a dual nanoparticle labeling strategy that integrates ultrasound (US) and photoacoustic (PA) imaging with magnetic guidance to enable image‐guided magnetic localization and retention of mesenchymal stromal cells (MSCs), together with quantitative longitudinal monitoring of the associated nanoparticle‐derived photocoustic signal. Silica‐coated gold nanorods provide photoacoustic contrast, while iron oxide nanoparticles introduce magnetic responsiveness, with nanoparticles altering neither MSC viability nor functionality. Combined loading yields a modular nanoparticle‐augmented cell system that responds to external magnetic fields and can be monitored before, during, and after delivery. Using both intramuscular and intravenous delivery routes, magnetic exposure increased acute localization, and the resulting nanoparticle‐associated photoacoustic signal distribution was monitored longitudinally using three‐dimensional photoacoustic metrics that quantify total signal, spatial footprint, and hotspot dynamics. Together, the platform establishes a foundation for image‐guided cellular localization and offers principles for combining orthogonal nanomaterials within a single cell to support improved retention and quantitative in vivo monitoring across cell therapy applications.
No takes yet. Share an insight, caveat, or question.
Jhunjhunwala et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: